Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today approved Qiagen's therascreen EGRF test as a companion diagnostic test for AstraZeneca's Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small lung cancer. 

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.